FRUZAQLA FDA approval date

The FDA approved FRUZAQLA on 8 Nov 2023.

FDA approval date
8 Nov 2023

Drug identity has not yet been verified against registry records

Also recorded as FRUQUINTINIB

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2023-11-08DayFRUZAQLAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA217564", "applicant_as_listed_by_fda": "TAKEDA PHARMS USA", "brand_names": ["FRUZAQLA"], "active_ingredients": ["FRUQUINTINIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20231108", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026